- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 101089, 7 pages
Antiadherent and Antibiofilm Activity of Humulus lupulus L. Derived Products: New Pharmacological Properties
1Department of Haemostatic Disorders, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland
2Department of Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland
3Department of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, Poland
Received 16 April 2013; Revised 16 August 2013; Accepted 20 August 2013
Academic Editor: Matthias Labrenz
Copyright © 2013 Marcin Rozalski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. R. Chadwick, G. F. Pauli, and N. R. Farnsworth, “The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties,” Phytomedicine, vol. 13, no. 1-2, pp. 119–131, 2006.
- B. Olas, J. Kolodziejczyk-Czepas, B. Wachowicz, D. Jedrejek, A. Stochmal, and W. Oleszek, “The extract from hop cones in plasma protects against changes following exposure to peroxynitrite,” Central European Journal of Biology, vol. 6, no. 6, pp. 990–996, 2011.
- M. Van Cleemput, K. Cattoor, K. De Bosscher, G. Haegeman, D. De Keukeleire, and A. Heyerick, “Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds,” Journal of Natural Products, vol. 72, no. 6, pp. 1220–1230, 2009.
- P. Zanoli and M. Zavatti, “Pharmacognostic and pharmacological profile of Humulus lupulus L.,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 383–396, 2008.
- S. Bhattacharya, S. Virani, M. Zavro, and G. J. Haas, “Inhibition of Streptococcus mutans and other oral Streptococci by hop (Humulus lupulus L.) constituents,” Economic Botany, vol. 57, no. 1, pp. 118–125, 2003.
- C. Gerhäuser, “Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites,” Molecular Nutrition and Food Research, vol. 49, no. 9, pp. 827–831, 2005.
- P. Natarajan, S. Katta, I. Andrei, V. Babu Rao Ambati, M. Leonida, and G. J. Haas, “Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics,” Phytomedicine, vol. 15, no. 3, pp. 194–201, 2008.
- R. Shapouri and M. Rahnema, “Evaluation of antimicrobial effect of hops extracts on intramacrophages Brucella abortus and B. melitensis,” Jundishapur Journal of Microbiology, vol. 4, no. 1, pp. S51–S58, 2011.
- N. Yamaguchi, K. Satoh-Yamaguchi, and M. Ono, “In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris,” Phytomedicine, vol. 16, no. 4, pp. 369–376, 2009.
- N. Høiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu, “Antibiotic resistance of bacterial biofilms,” International Journal of Antimicrobial Agents, vol. 35, no. 4, pp. 322–332, 2010.
- A. Dürig, I. Kouskoumvekaki, R. M. Vejborg, and P. Klemm, “Chemoinformatics-assisted development of new anti-biofilm compounds,” Applied Microbiology and Biotechnology, vol. 87, no. 1, pp. 309–317, 2010.
- S. Gibbons, “Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities,” Planta Medica, vol. 74, no. 6, pp. 594–602, 2008.
- J. G. Bordonaba and L. A. Terry, “Biochemical profiling and chemometric analysis of seventeen UK-grown black currant cultivars,” Journal of Agricultural and Food Chemistry, vol. 56, no. 16, pp. 7422–7430, 2008.
- T. Swain and W. E. Hillis, “The phenolic constituents of Prunus domestica. I. The quantitative analysis of phenolic constituents,” Journal of the Science of Food and Agriculture, vol. 10, no. 1, pp. 63–68, 1959.
- D. Rösch, M. Bergmann, D. Knorr, and L. W. Kroh, “Structure-antioxidant efficiency relationships of phenolic compounds and their contribution to the antioxidant activity of sea buckthorn juice,” Journal of Agricultural and Food Chemistry, vol. 51, no. 15, pp. 4233–4239, 2003.
- Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, vol. 29 of Approved standard M07-A8, no. 2, Clinical and Laboratory Standards Institute (CLSI), Wayne, NJ, USA, 8th ed edition, 2009.
- Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Disk Susceptibility Tests, vol. 29 of Approved standard M02-A10, no. 1, Wayne, NJ, USA, 10th edition, 2009.
- T. P. Cushnie, V. E. S. Hamilton, D. G. Chapman, P. W. Taylor, and A. J. Lamb, “Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin,” Journal of Applied Microbiology, vol. 103, no. 5, pp. 1562–1567, 2007.
- A. Budzyńska, M. Rózalski, W. Karolczak, M. Wieckowska-Szakiel, B. Sadowska, and B. Rózalska, “Synthetic 3-arylideneflavanones as inhibitors of the initial stages of biofilm formation by Staphylococcus aureus and Enterococcus faecalis,” Zeitschrift fur Naturforschung C, vol. 66, no. 3-4, pp. 104–114, 2011.
- K. Sakai, N. Koyama, T. Fukuda, Y. Mori, H. Onaka, and H. Tomoda, “Search method for inhibitors of staphyloxanthin production by methicillin-resistant Staphylococcus aureus,” Biological and Pharmaceutical Bulletin, vol. 35, no. 1, pp. 48–53, 2012.
- T. P. Cushnie and A. J. Lamb, “Recent advances in understanding the antibacterial properties of flavonoids,” International Journal of Antimicrobial Agents, vol. 38, no. 2, pp. 99–107, 2011.
- M. Oshugi, P. Basnet, S. Kadota et al., “Antibacterial activity of traditional medicines and an active constituent lupulone from Humulus lupulus against Helicobacter pylori,” Journal of Traditional Chinese Medicine, vol. 14, no. 3, pp. 186–191, 1997.
- J. E. Serkani, B. N. Isfahani, H. G. Safaei, R. K. Kermanashahi, and G. Asghari, “Evaluation of the effect of Humulus lupulus alcoholic extract on rifampin-sensitive and resistant isolates of Mycobacterium tuberculosis,” Research in Pharmaceutical Sciences, vol. 7, no. 4, pp. 235–242, 2012.
- W. J. Simpson and A. R. W. Smith, “Factors affecting antibacterial activity of hop compounds and their derivatives,” Journal of Applied Bacteriology, vol. 72, no. 4, pp. 327–334, 1992.
- M. Stavri, R. Schneider, G. O'Donnell, D. Lechner, F. Bucar, and S. Gibbons, “The antimycobacterial components of hops (Humulus lupulus) and their dereplication,” Phytotherapy Research, vol. 18, no. 9, pp. 774–776, 2004.
- H. L. Sung, J. K. Hyun, S. L. Jung, I. Lee, and Y. K. Bok, “Inhibition of topoisomerase I activity and efflux drug transporters' expression by xanthohumol from hops,” Archives of Pharmacal Research, vol. 30, no. 11, pp. 1435–1439, 2007.
- G. R. Siragusa, G. J. Haas, P. D. Matthews et al., “Antimicrobial activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and caecum,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 4, pp. 853–858, 2008.
- V. Srinivasan, D. Goldberg, and G. J. Haas, “Contributions to the antimicrobial spectrum of hop constituents,” Economic Botany, vol. 58, pp. S230–S238, 2004.
- M. Teuber and A. F. Schmalreck, “Membrane leakage in Bacillus subtilis 168 induced by the hop constituents lupulone, humulone, isohumulone and humulinic acid,” Archiv für Mikrobiologie, vol. 94, no. 2, pp. 159–171, 1973.
- E. A. Palombo, “Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 680354, 15 pages, 2011.
- H. M. Nguyen and C. J. Graber, “Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?” The Journal of Antimicrobial Chemotherapy, vol. 65, no. 1, pp. 24–36, 2010.
- S. Stefani, D. Bongiorno, G. Mongelli, and F. Campanile, “Linezolid resistance in staphylococci,” Pharmaceuticals, vol. 3, no. 7, pp. 1988–2006, 2010.
- A. W. Maresso and O. Schneewind, “Sortase as a target of anti-infective therapy,” Pharmacological Reviews, vol. 60, no. 1, pp. 128–141, 2008.